⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5956026 | 0.78 | — | — | |
| SCHEMBL5956305 | 0.78 | — | — | |
| SCHEMBL28410831 | 0.76 | ADRA2C (0.32) | — | |
| SCHEMBL19308799 | 0.73 | — | — | |
| SCHEMBL8135694 | 0.64 | GAA (0.30) | — | |
| SCHEMBL2383860 | 0.62 | — | — | |
| SCHEMBL6233396 | 0.61 | KDM4E (0.36) | — | |
| SCHEMBL28231995 | 0.61 | ADRA2C (0.40) | — | |
| SCHEMBL6234575 | 0.59 | — | — | |
| SCHEMBL11024134 | 0.58 | GAA (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1583745-A1 | 1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2005-10-12 | — | — | EP | claimed |
| EP-1195373-B1 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 2005-03-23 | — | — | EP | claimed |
| WO-2004063163-A1 | 1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2004-07-29 | — | — | WO | claimed |
| US-6696301-B2 | SUBJECTING A SAMPLE CONTAINING 5-HYDROXYCREATININ TO HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) IN A STRONGLY ACIDIC CATION-EXCHANGE RESIN MEDIUM (STYRENE-DIVINYLBEZENE RESIN) USING A SEPARATION SOLVENT HAVING ACIDIC PH | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2004-02-24 | — | — | US | claimed |
| US-20020137224-A1 | Method for determination of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2002-09-26 | — | — | US | claimed |
| EP-1195373-A2 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2002-04-10 | — | — | EP | claimed |
| JP-4161854-A | — | — | None | — | — | JP | disclosed |
| JP-5119038-A | — | — | None | — | — | JP | disclosed |
| EP-1195373-B1 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 2005-03-23 | — | — | EP | disclosed |
| EP-1195373-B1 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 2005-03-23 | — | — | EP | disclosed |
| US-6696301-B2 | SUBJECTING A SAMPLE CONTAINING 5-HYDROXYCREATININ TO HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) IN A STRONGLY ACIDIC CATION-EXCHANGE RESIN MEDIUM (STYRENE-DIVINYLBEZENE RESIN) USING A SEPARATION SOLVENT HAVING ACIDIC PH | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2004-02-24 | — | — | US | disclosed |
| US-6696301-B2 | SUBJECTING A SAMPLE CONTAINING 5-HYDROXYCREATININ TO HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) IN A STRONGLY ACIDIC CATION-EXCHANGE RESIN MEDIUM (STYRENE-DIVINYLBEZENE RESIN) USING A SEPARATION SOLVENT HAVING ACIDIC PH | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2004-02-24 | — | — | US | disclosed |
| US-6696301-B2 | SUBJECTING A SAMPLE CONTAINING 5-HYDROXYCREATININ TO HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) IN A STRONGLY ACIDIC CATION-EXCHANGE RESIN MEDIUM (STYRENE-DIVINYLBEZENE RESIN) USING A SEPARATION SOLVENT HAVING ACIDIC PH | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2004-02-24 | — | — | US | disclosed |
| EP-1195373-A2 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2002-04-10 | — | — | EP | disclosed |
| EP-1195373-A2 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2002-04-10 | — | — | EP | disclosed |
| JP-2002107350-A | MEASURING METHOD OF 5-HYDROXYCREATININE | NIPPON ZOKI PHARMACEUT CO LTD | 2002-04-10 | — | — | JP | disclosed |
| EP-1195373-A2 | Method for separation of 5-hydroxycreatinine | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2002-04-10 | — | — | EP | disclosed |
| JP-2000352564-A | METHOD FOR DETERMINING 5-HYDROXYCREATININE | NIPPON ZOKI PHARMACEUT CO LTD | 2000-12-19 | — | — | JP | disclosed |
| JP-H05119038-A | MEASURING METHOD FOR SUBSTANCE IN VIVO | NIPPON ZOKI PHARMACEUT CO LTD | 1993-05-14 | — | — | JP | disclosed |
| JP-H04161854-A | METHOD FOR MEASURING MATERIAL IN ORGANISM | NIPPON ZOKI PHARMACEUT CO LTD | 1992-06-05 | — | — | JP | disclosed |